Pembrolizumab vs Sildenafil
Pembrolizumab vs Sildenafil: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Sildenafil.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Sildenafil: Selective PDE5 inhibitor increasing cGMP.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days; Sildenafil β 4 hours.
Chemical Properties
Molecular Formula: Sildenafil β C22H30N6O4S.
Molecular Weight: Sildenafil β 474.5800 g/mol.
Type: Pembrolizumab β Antibody; Sildenafil β Small molecule.